145 related articles for article (PubMed ID: 10369359)
41. Bilateral Thalamic Glioma: Case Report and Review of the Literature.
Balasa A; Balasa R; Egyed-Zsigmond I; Chinezu R
Turk Neurosurg; 2016; 26(2):321-4. PubMed ID: 26956834
[TBL] [Abstract][Full Text] [Related]
42. [Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions].
Ando K; Ishikura R; Nagami Y; Morikawa T; Takada Y; Ikeda J; Nakao N; Matsumoto T; Arita N
Nihon Igaku Hoshasen Gakkai Zasshi; 2004 Mar; 64(3):121-6. PubMed ID: 15148787
[TBL] [Abstract][Full Text] [Related]
43. High-grade dural arteriovenous fistula simulating a bilateral thalamic neoplasm.
Sugrue PA; Hurley MC; Bendok BR; Surdell DL; Gottardi-Littell N; Futterer SF; Muro K; Batjer HH
Clin Neurol Neurosurg; 2009 Sep; 111(7):629-32. PubMed ID: 19482418
[TBL] [Abstract][Full Text] [Related]
44. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
45. Thalamic metabolic abnormalities in patients with Huntington's disease measured by magnetic resonance spectroscopy.
Casseb RF; D'Abreu A; Ruocco HH; Lopes-Cendes I; Cendes F; Castellano G
Braz J Med Biol Res; 2013 Aug; 46(8):722-7. PubMed ID: 23969973
[TBL] [Abstract][Full Text] [Related]
46. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy.
Vuori K; Kankaanranta L; Häkkinen AM; Gaily E; Valanne L; Granström ML; Joensuu H; Blomstedt G; Paetau A; Lundbom N
Radiology; 2004 Mar; 230(3):703-8. PubMed ID: 14739313
[TBL] [Abstract][Full Text] [Related]
47. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls.
Mirza Y; O'Neill J; Smith EA; Russell A; Smith JM; Banerjee SP; Bhandari R; Boyd C; Rose M; Ivey J; Renshaw PF; Rosenberg DR
J Child Neurol; 2006 Feb; 21(2):106-11. PubMed ID: 16566872
[TBL] [Abstract][Full Text] [Related]
48. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
49. Child with radiologically recurrent thalamic tumor.
Mandiwanza T; Kaliaperumal C; Mulligan L; Ryan E; Looby S; Caird J; Brett F
Brain Pathol; 2017 Mar; 27(2):239-240. PubMed ID: 28217956
[No Abstract] [Full Text] [Related]
50. Two children with tremor.
Liu H; Pringsheim T; Thompson GC
CMAJ; 2015 Apr; 187(7):512-517. PubMed ID: 25404400
[No Abstract] [Full Text] [Related]
51. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.
Galanaud D; Chinot O; Nicoli F; Confort-Gouny S; Le Fur Y; Barrie-Attarian M; Ranjeva JP; Fuentès S; Viout P; Figarella-Branger D; Cozzone PJ
J Neurosurg; 2003 Feb; 98(2):269-76. PubMed ID: 12593610
[TBL] [Abstract][Full Text] [Related]
52. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
54. Discrepant MR spectroscopic and perfusion imaging results in a case of malignant transformation of cerebral glioma.
Wu WC; Chen CY; Chung HW; Juan CJ; Hsueh CJ; Gao HW
AJNR Am J Neuroradiol; 2002; 23(10):1775-8. PubMed ID: 12427638
[TBL] [Abstract][Full Text] [Related]
55. Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method.
Walecki J; Tarasów E; Kubas B; Czemicki Z; Lewko J; Podgórski J; Sokól M; Grieb P
Acad Radiol; 2003 Feb; 10(2):145-53. PubMed ID: 12583565
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic difficulties in childhood bilateral thalamic astrocytomas.
Gudowius S; Engelbrecht V; Messing-Jünger M; Reifenberger G; Gärtner J
Neuropediatrics; 2002 Dec; 33(6):331-5. PubMed ID: 12571791
[TBL] [Abstract][Full Text] [Related]
57. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement.
Kimura T; Sako K; Gotoh T; Tanaka K; Tanaka T
NMR Biomed; 2001 Oct; 14(6):339-49. PubMed ID: 11599032
[TBL] [Abstract][Full Text] [Related]
58. [Diagnosis of brain tumor with proton MR spectroscopy--the quantification of gliomas compared with normal brain].
Yu HW; Tanabe S; Yamaki T; Harada K; Hashi K
No Shinkei Geka; 2000 Dec; 28(12):1063-9. PubMed ID: 11193526
[TBL] [Abstract][Full Text] [Related]
59. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
[TBL] [Abstract][Full Text] [Related]
60. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
